Vendor status logFDA letter
Royal Peptides: status log
Site responding; FDA warning letter Aug 24 2026
Domains: royal-peptides.com · Last checked 2026-10-19 · Reviewed by Amino Wire Editorial Team
Summary
FDA's August 24, 2026 warning letter to Royal Peptides LLC (Boynton Beach, Florida) followed a July 2026 website review and named tirzepatide, semaglutide, retatrutide, SS-31, PT-141, tesamorelin and “BIMORELIN” products.
Dated facts
1 entries · newest first-
FDA warning letter
FDA warning letter 734884: seven products called unapproved new drugs under section 505(a).
Our site checks
automated · single location| Checked (UTC) | URL | HTTP | What loaded |
|---|---|---|---|
| 2026-10-19 06:21:50 | https://royal-peptides.com/ | 200 | HTTP 200. The response included add-to-cart markup, which suggests a storefront was being served. We did not place an order and cannot say whether orders ship. |
A page loading does not show that a business is lawful, that orders are fulfilled, or anything about product quality. We did not place orders.